ArticleAlzheimer's research & therapy2018

Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease.

Umesh Gangishetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.